/DISCLAIMER · RESEARCH_COMPOUND

This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.

/ENCLOMIPHENE
SERM / Ancillary

Enclomiphene Citrate (Androxal)

Selective Estrogen Receptor Modulator (SERM)

/HALF_LIFE
Approx. 10 hours (elimination), allowing daily oral dosing :contentReference[oaicite:9]{index=9}
/DELIVERY
Oral capsule

/WHAT_IT_IS

Enclomiphene is the isolated trans-isomer of clomiphene, designed to stimulate endogenous testosterone production without suppressing sperm or LH levels.

/USAGE

Investigated for treating secondary hypogonadism in men to restore testosterone while preserving fertility; off-label in male hormone therapy.

/MECHANISM_OF_ACTION

Antagonizes estrogen receptors in the hypothalamus/pituitary, preventing negative feedback and increasing GnRH, LH, FSH, which stimulates testicular testosterone and sperm production :contentReference[oaicite:1]{index=1}.

Reported Benefits

  • +Restores physiological testosterone levels in hypogonadal men :contentReference[oaicite:2]{index=2}
  • +Maintains or increases sperm count (unlike exogenous TRT) :contentReference[oaicite:3]{index=3}
  • +Elevates LH and FSH rather than suppressing them :contentReference[oaicite:4]{index=4}
  • +Favorable safety and side effect profile vs clomiphene :contentReference[oaicite:5]{index=5}

Reported Side Effects

  • Headache, nausea, abdominal discomfort (~1–2%) :contentReference[oaicite:6]{index=6}
  • Hot flashes, mood changes, acne, increased appetite (rare) :contentReference[oaicite:7]{index=7}
  • Low risk of thromboembolic events (<0.3%) and vision changes :contentReference[oaicite:8]{index=8}

/STACKED_WITH

Clomid (clomiphene) for alternate SERM/QC approachesAromatase inhibitors (e.g., anastrozole) if estrogen needs managementTRT (testosterone replacement therapy) for severe hypogonadism

/RESEARCH_NOTES

Phase II/III trials demonstrated normalization of testosterone, LH/FSH, and sperm counts in obese and secondary hypogonadal men; shows legacy effect lasting ≥1 week off-treatment :contentReference[oaicite:10]{index=10}; development discontinued by FDA in 2021 due to regulatory issues :contentReference[oaicite:11]{index=11}.

/REFERENCE

https://pubmed.ncbi.nlm.nih.gov/PMC5009465/

/RELATED

/TRACK_THIS

Browse all 89 in the app.

MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.

Last reviewed: 2026-06-04 · Reference only. Not medical advice. Consult a qualified physician.